Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. The impact of blood type on transfusion after major emergency abdominal surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Calcium in drinking water: effect on iron stores in Danish blood donors-results from the Danish Blood Donor Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Magnetic Resonance Imaging: A New Tool to Optimize the Prediction of Fetal Anemia?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Copenhagen Baby Heart Study: a population study of newborns with prenatal inclusion

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
BACKGROUND: The objective was to investigate whether women who develop preeclampsia can be identified in a routine analysis when determining fetal RHD status at 25 weeks' gestation in combination with PAPP-A levels at the first-trimester combined risk assessment for Trisomy 21. STUDY DESIGN AND METHODS: D- women participating in the routine antenatal RHD screening program in the capital region of Denmark were retrospectively studied. We used a standard dilution curve to quantify the amounts of cell-free fetal DNA (cffDNA) and divided women into groups according to cffDNA levels. PAPP-A was measured at 11 to 14 weeks. Information about pregnancy outcome and complications was obtained from the National Fetal Medicine Database, medical charts, and discharge letters. RESULTS: The odds ratio (OR) of developing severe preeclampsia given a cffDNA level above the 90th percentile compared to cffDNA below the 90th percentile was 8.1 (95% confidence interval [CI], 2.6-25.5). The OR of developing mild preeclampsia given a cffDNA level below the 5th percentile compared to cffDNA levels above the 5th percentile was 3.6 (95% CI, 1.1-11.7). PAPP-A levels below the 5th percentile were associated with mild preeclampsia, but adding it to the analysis did not increase the detection rate (DR). CONCLUSION: Women with cffDNA levels below the 5th percentile and above the 90th percentile quantified at 25 weeks' gestation are at increased risk of developing preeclampsia. Adding PAPP-A levels to the analysis did not increase the DR of preeclampsia.
Original languageEnglish
JournalTransfusion
Volume53
Issue number9
Pages (from-to)1956-1964
Number of pages9
ISSN0041-1132
DOIs
Publication statusPublished - 16 Jan 2013

ID: 38977618